EZADERM

This brand name is authorized in Nigeria.

Active ingredients

The drug EZADERM contains a combination of these active pharmaceutical ingredients (APIs):

1	Fusidic acid UNII 59XE10C19C - FUSIDIC ACID
	Fusidic acid belongs to a unique group of antibiotics, the fusidanes, which act to inhibit bacterial protein synthesis by blocking the lengthening of factor G. Fusidic acid is active against staphylococcus epidermidis and methicillin resistant staphylococci.
	Read more about Fusidic acid
2	Betamethasone UNII 9842X06Q6M - BETAMETHASONE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0382	Cream	Ezaderm Cream CREAM 0.1%; 0.5%; 0.025% 1 x 15 g	Cream EZADERM CREAM EZADERM FUSIDIC ACID 2%W/W, BETAMETHASONE 0.1%W/W POM CREAM 1 X 15G ANTIBACTERIAL, CORTICOSTEROID FOUNDATION PHARMACY & STORES LTD., 25, EMMANUEL STREET, BARIGA, LAGOS STATE. THE UNITED PHARMACEUTICALS MANUFACTURING CO. LTD., HAI AL-RAQEEM- SAHAB, AMMAN, 11591 JORDAN. GMP- RBC; LR- SATIS; FEES- PAID; NP:NA 31/05/2019 C4-0382	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07CC01	Betamethasone and antibiotics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics
Discover more medicines within D07CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0382